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Katz et al provide results from a prospective cohort analysis of
patients undergoing primary stenting of the superficial femoral and
popliteal arteries. It is important to recognize that to achieve the
degree of success reported in this series, the authors excluded 52
patients, or nearly a quarter of the greater cohort, because of
orificial superficial femoral artery (SFA) occlusions or combined
SFA, popliteal and/or tibial artery occlusions. These patterns of
disease represent red flags to most seasoned endovascular special-
ists, who view them as contraindications to intervening on the
femoral and popliteal segments. It is likely that the clinical judg-
ment shown in avoiding interventions on patients with these
patterns of disease allowed the authors to achieve such safe, effec-
tive, and durable outcomes.
By defining loss of primary patency as “development of reste-
nosis of 50% or greater” in addition to stent occlusion, the article
sets a high standard in terms of duplex-based surveillance and
definition of stent failure. Today, it is too common to have studies
define loss of primary patency as occurring only with stent occlu-
sion or in some instances only if the extremity requires reinterven-
tion (ie, “target lesion reintervention”).
This less stringent definition of primary patency means that as
long as the extremity has not required a subsequent procedure, theintervention being studied is categorized in the primary patency
group. In this context, the current article presents a welcome and
realistic assessment of SFA intervention that may actually underes-
timate patency. Such rigorous methodology is more in line with
that historically applied to the study of open bypass procedures and
should be promoted as a standard within the endovascular com-
munity, including endovascular trainees.
The primary limitation of the report is the absence of control
group treated without primary stenting. This limitation is common
among studies of peripheral interventions and is predictable in this
particular group of patients, where routine or primary nitinol
stenting is already such an accepted method of treatment. The
absence of a control group limits the reader’s ability to draw
conclusions about whether primary stenting extends the anatomic
limits of lower extremity intervention compared with balloon
angioplasty alone. As such, the study’s greatest value is reporting
success rates and outcomes, which it does effectively.
The strengths of the study, including its prospective nature,
length of duplex-based follow-up, and rigorous definition of pri-
mary patency, combine to provide a useful report on infrainguinal
endovascular intervention. The authors are to be congratulated on
the effort taken to complete this important work.
